Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 12/20 | 0.82 |
| ▸ | AVPR1B | P47901 | 9/20 | 0.82 |
| ▸ | AVPR2 | P30518 | 8/20 | 0.82 |
| ▸ | OXTR | P30559 | 7/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.77 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.77 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Felypressin SCHEMBL1650172 | 1.00 | AVPR1A (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL31138866 | 1.00 | AVPR1A (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL33291 | 1.00 | AVPR1A (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL4405496 | 0.98 | AVPR1A (0.79) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Lypressin SCHEMBL1650587 | 0.97 | OXTR (0.87) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Lypressin SCHEMBL33287 | 0.97 | OXTR (0.87) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL5199973 | 0.97 | AVPR1A (0.77) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Lypressin SCHEMBL29471105 | 0.96 | OXTR (0.84) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Ornipressin SCHEMBL1650220 | 0.95 | AVPR1A (0.88) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Ornipressin SCHEMBL296322 | 0.95 | AVPR1A (0.88) | AVPR1AAVPR1BAVPR2OXTRTBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3400000-B1 | METHODS FOR ADMINISTERING ANGIOTENSIN II | LA JOLLA PHARMA LLC (US) | 2023-12-06 | — | — | EP | claimed |
| EP-3247376-B1 | TREATING PROSTATE CANCER | SUNNYBROOK RES INST (CA) | 2021-07-14 | — | — | EP | claimed |
| EP-1744683-B1 | APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE AGENTS | ALZA CORP (US) | 2016-03-16 | — | — | EP | claimed |
| EP-2326341-B1 | Oxytocin formulations and uses thereof | UNIV GRONINGEN (NL) | 2012-07-04 | — | — | EP | claimed |
| EP-1587504-B1 | Process for the manufacture of a thin film comprising heat sensitive actives | MONOSOLRX LLC (US) | 2012-04-18 | — | — | EP | claimed |
| EP-0938338-B1 | CARRIER COMPOSITION FOR INFLUENCING THE TIGHT JUNCTION PERMEABILITY | GHYSSAERT JORIS ROSA MICHAEL (BE) | 2009-09-30 | — | — | EP | claimed |
| US-20070213259-A1 | Method for stabilizing blood pressure in hemodialysis subjects | INTRADIALYTIC PHARMACEUTICALS, LLC | 2007-09-13 | — | — | US | claimed |
| US-7183255-B2 | Method for stabilizing blood pressure in hemodialysis subjects | INTRADIALYTIC PHARMACEUTICALS (US) | 2007-02-27 | — | — | US | claimed |
| US-20040229798-A1 | Method for stabilizing blood pressure in hemodialysis subjects | INTRADIALYTIC PHARMACEUTICALS, LLC | 2004-11-18 | — | — | US | claimed |
| WO-2004075783-A2 | A METHOD FOR STABILIZING BLOOD PRESSURE IN HEMODIALYSIS SUBJECTS | LANDRY DONALD W (US) | 2004-09-10 | — | — | WO | claimed |
| EP-3903733-B1 | FLUID EXCHANGE APPARATUS | FORSIGHT VISION4 INC (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-4249059-B1 | AN APPARATUS FOR COLLECTING A SAMPLE OF FLUID FROM A RESERVOIR CHAMBER OF A THERAPEUTIC DEVICE FOR THE EYE | FORSIGHT VISION4 INC (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-3217924-B1 | EXPANDABLE DRUG DELIVERY DEVICES | FORSIGHT VISION4 INC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-12251336-B2 | Expandable drug delivery devices and methods of use | FORSIGHT VISION4, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| US-12201556-B2 | Porous structures for extended release drug delivery devices | FORSIGHT VISION4, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| EP-0586666-A4 | — | — | 1994-08-03 | — | — | EP | disclosed |
| EP-0586666-A1 | USER ACTIVATED IONTOPHORETIC DEVICE AND METHOD FOR USING SAME. | BECTON DICKINSON CO (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1993018727-A1 | USER ACTIVATED IONTOPHORETIC DEVICE AND METHOD FOR USING SAME | BECTON DICKINSON AND COMPANY (US) | 1993-09-30 | — | — | WO | disclosed |
| US-4101677-A | Aminotetralins and use in inducing anesthesia | ABBOTT LABORATORIES (US) | 1978-07-18 | — | — | US | disclosed |
| US-4057582-A | Aminotetralins and use in inducing anesthesia | ABBOTT LABORATORIES (US) | 1977-11-08 | — | — | US | disclosed |